Corteva, Inc. ranks among the world’s largest agriculture companies, providing farmers with seeds, crop-protection products, and digital tools that support more efficient food production. I follow CTVA because the business sits at the heart of structural trends like population growth, rising food demand, and the push for sustainable farming. As a pure-play agriculture name, its results track closely with global ag markets rather than broader industrial or chemical cycles.
The company’s story combines two established agricultural franchises. Its lineage includes DuPont’s ag operations, which date back to the firm’s founding in 1802, and Pioneer Hi-Bred, the Iowa seed specialist founded in 1926. These assets were grouped under DowDuPont before the spin-off that created Corteva, Inc., which began trading on the New York Stock Exchange under the ticker CTVA in June 2019. Headquarters are in Indianapolis, Indiana, and the firm employs roughly 21,500 people globally.
Revenue comes mainly from two segments. The Seed segment develops commercial seeds that pair strong germplasm with traits for better resistance to weather, pests, diseases, and herbicides; key brands here are Pioneer and Brevant, covering corn, soybeans, canola, sunflower, and rice. The Crop Protection segment supplies herbicides, insecticides, fungicides, nitrogen stabilizers, and seed-applied technologies. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Corteva further offers digital agriculture solutions that aid data-driven planting and field decisions. Sales reach farmers, cooperatives, and distributors across North America, Latin America, Europe, the Middle East, Africa, and Asia Pacific.
In a competitive field, Corteva develops both seeds and crop-protection technologies, going head-to-head with Bayer, Syngenta Group, BASF, and FMC. Standout offerings include the Enlist weed-control system and products aimed at evolving resistance issues.
Long-term drivers include a growing global population, higher demand for protein-rich diets, and the need to produce more food on limited land. These factors underpin demand for high-yielding seeds and reliable crop-protection inputs. Competitive strengths lie in brand recognition, research depth, farmer relationships, and worldwide distribution. The seed business in particular benefits from proprietary genetics that are hard to copy. Demand tends to recur each season as farmers buy inputs annually.
From a financial standpoint, Corteva generates annual net sales in the tens of billions. Investors track revenue growth, segment margins, and free cash flow, along with capital returns via dividends and buybacks. From what I see, these elements give the business a solid profile within the ag-input space.
Agricultural markets are seasonal and weather-sensitive, so results can swing from year to year or quarter to quarter. Poor growing conditions or extreme weather in major regions can dampen demand. Intense competition, including from generic manufacturers, may pressure pricing. Commodity prices for corn and soybeans affect farmers’ spending power and planting choices, tying results to broader cycles. Regulatory shifts around crop-protection chemicals and genetically modified traits can limit product access, while currency moves and the need for ongoing R&D investment add further variables.
Corteva presents a focused, large-scale agriculture business with exposure across seeds, crop protection, and digital tools. Its brands, research capabilities, and global footprint position it as a meaningful player in the agricultural-input sector. For investors seeking exposure to food-security and productivity themes, CTVA offers one avenue—while still carrying the typical risks of a cyclical, weather-exposed industry.
In my own analysis, I frequently rely on Tickeron’s AI Screener to screen stocks and ETFs by technical indicators, fundamentals, volatility, trends, AI signals, and industry filters. It helps surface ideas that align with specific strategies and quickly compare names like CTVA against peers, saving time when building or refining a watchlist.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
CTVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 39 cases where CTVA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CTVA's RSI Oscillator exited the oversold zone, 22 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 53 cases where CTVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CTVA as a result. In 48 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for CTVA just turned positive on November 10, 2026. Looking at past instances where CTVA's MACD turned positive, the stock continued to rise in 30 of 46 cases over the following month. The odds of a continued upward trend are 65%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTVA advanced for three days, in 216 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
CTVA moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CTVA crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The Aroon Indicator for CTVA entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.316) is normal, around the industry mean (-0.492). P/E Ratio (7.778) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.011) is also within normal values, averaging (0.867). Dividend Yield (0.026) settles around the average of (0.126) among similar stocks. CTVA's P/S Ratio (3.069) is slightly higher than the industry average of (1.476).
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. CTVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company, which engages in the provision of agricultural products.
Industry ChemicalsAgricultural